Bottom

Hyatt buys Apple Leisure Group and its 100 hotels for $2.7 billion

Hyatt Hotels (NYSE: H) agreed to buy resort operator Apple Leisure Group from KKR and KSL Capital Partners for $2.7 billion in cash.

Why Gavin Newsom Faces a Recall Election in California

In 2019, still settling into his new home in the state’s creepy, gothic governor’s mansion, Gavin Newsom told an Axios interviewer, “California is what America is going to look like.” Then, perhaps reflecting on his Hollywood benefactors, he added for emphasis, “California is America’s coming attraction.”

The Great Parent Revolt

As overreach in classrooms by progressive school administrators, nonprofits and the federal government has reached new heights, parents are stepping up to fight back.

Does the World Have the Will To Stop Xi Jinping?

There is an old Soviet tale about Foreign Minister Andrei Gromyko. At lunchtime, he would retreat into his office and stare at the map of the world. The map was centered on the Soviet Union. The old Bolshevik would just glare at it as if it were a giant chessboard awaiting Moscow’s next move.

Philip Morris International raises bid to acquire drug manufacturer Vectura

Philip Morris International has raised its bid against Carlyle to acquire Vectura, a U.K.-based drug manufacturer specializing in inhaled medicines, to 1.02 billion pounds ($1.41 billion). The U.K.'s Takeover Panel said that the deal could enter a rare head-to-head auction.

Vax Manufacturers Make Combined $18.6 Billion So Far in 2021

Coronavirus vaccine sales projected to earn drug companies $60 billion by year's end.

Wisconsin Assembly Speaker names special counsel to expand probe of 2020 election

Retired Supreme Court Justice will have resources and authority to conduct a "top to bottom" probe, Speaker Robin Vos declared.

Stocks slide as Amazon weighs down tech sector

Amazon Inc.'s revenue topped $100B for third straight quarter.

Ivermectin ‘Safe,’ ‘Effective’ COVID Treatment: WSJ Op-Ed

A Wall Street Journal op-ed claims the FDA is "attacking a safe, effective drug," Ivermectin, even though the FDA itself certified the medication in 1996.

AOC scores near bottom on effectiveness study

Rep. Alexandria Ocasio-Cortez of New York has become one of the most recognizable figures in Washington, but she’s falling flat on the effectiveness scale.

Latest news

- Advertisement -spot_img